Patel Priyansh, Davitashvili Besiki, Chitturi Sai Sujana, Gadaevi Mari, Patel Diya, Tallapalli Jayanth Reddy, Butchireddy Jyothsna, Suresh Ria, Nannegari Jayanth Jhishnu, Slathia Shivam
Department of Cardiovascular Medicine, University of Miami Miller School of Medicine, Miami, USA.
Department of Internal Medicine, Medical College, Baroda, Vadodara, IND.
Cureus. 2025 Jul 7;17(7):e87494. doi: 10.7759/cureus.87494. eCollection 2025 Jul.
Interventional cardiology has recently advanced with innovations such as percutaneous transluminal coronary angioplasty (PTCA), transcatheter aortic valve replacement (TAVR), and the emergence of artificial intelligence (AI) as a transformative tool. This systematic review explored the current landscape, methodologies, and applications of AI in interventional cardiology. A comprehensive literature search was conducted following preferred reporting guidelines, identifying 20 studies after data extraction and quality assessment. AI-particularly machine learning (ML) and deep learning (DL)-enhances diagnostic accuracy and procedural efficiency. ML aids in arrhythmia detection and coronary plaque characterization, while DL supports imaging interpretation, robotic navigation, and catheter tracking. Clinical applications show AI's potential in predicting myocardial infarction, guiding personalized treatment, and improving resource management. Despite these benefits, challenges such as data privacy, algorithm transparency, and generalizability remain. Addressing these requires collaborative efforts and robust data sharing. Future priorities include integrating AI into routine clinical workflows, resolving regulatory barriers, and ensuring interpretability. Multidisciplinary collaboration is essential to address ethical considerations and uphold patient safety. The integration of AI in interventional cardiology offers significant potential to enhance patient care, procedural precision, and resource utilization. However, its adoption must be guided by careful attention to ethical, technical, and regulatory constraints. Overcoming these barriers through coordinated efforts may allow AI to redefine standards in cardiovascular care and enable a more precise, efficient, and patient-centered approach to interventional cardiology.
近年来,介入心脏病学随着经皮腔内冠状动脉成形术(PTCA)、经导管主动脉瓣置换术(TAVR)等创新技术以及作为变革性工具的人工智能(AI)的出现而取得了进展。本系统综述探讨了人工智能在介入心脏病学中的现状、方法和应用。按照首选报告指南进行了全面的文献检索,在数据提取和质量评估后确定了20项研究。人工智能,尤其是机器学习(ML)和深度学习(DL),提高了诊断准确性和手术效率。机器学习有助于心律失常检测和冠状动脉斑块特征分析,而深度学习则支持影像解读、机器人导航和导管跟踪。临床应用显示了人工智能在预测心肌梗死、指导个性化治疗和改善资源管理方面的潜力。尽管有这些好处,但数据隐私、算法透明度和可推广性等挑战仍然存在。解决这些问题需要共同努力和强大的数据共享。未来的优先事项包括将人工智能整合到常规临床工作流程中、解决监管障碍以及确保可解释性。多学科合作对于解决伦理问题和维护患者安全至关重要。人工智能在介入心脏病学中的整合为提高患者护理、手术精度和资源利用提供了巨大潜力。然而,其采用必须谨慎关注伦理、技术和监管限制。通过协调努力克服这些障碍可能会使人工智能重新定义心血管护理标准,并实现一种更精确、高效和以患者为中心的介入心脏病学方法。
Front Public Health. 2025-2-13
Semin Hematol. 2025-6-16
J Pharmacokinet Pharmacodyn. 2025-6-16
J Robot Surg. 2025-1-7
JACC Cardiovasc Interv. 2023-10-23
J Clin Med. 2023-7-11
Med Image Anal. 2022-11
Cardiol Ther. 2022-9